Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Loans and Notes Receivables (2025)

Xtant Medical Holdings (XTNT) reported Loans and Notes Receivables of $10.5 million for Q4 2025.

Xtant Medical Holdings (XTNT) has 1 years of Loans and Notes Receivables data on file, last reported at $10.5 million in Q4 2025.

  • Quarterly Loans and Notes Receivables changed N/A year-over-year to $10.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.5 million (changed N/A YoY) and the FY2025 annual result came in at $10.5 million, changed N/A from the prior year.
  • Loans and Notes Receivables was little changed at $10.5 million in Q4 2025 per XTNT's latest filing.
  • Across five years, Loans and Notes Receivables topped out at $10.5 million in Q4 2025 and bottomed at $10.5 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Loans & Notes Receiv. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn 10.46 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 10.46 Mn